MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Synaptic density and α-synuclein oligomers in skin biopsies: differences between idiopathic and GBA-linked Parkinson’s disease

E. Contaldi, S. Mazzetti, M. Basellini, V. Ferri, E. Cereda, I. Isaias, G. Pezzoli, G. Cappelletti (Milan, Italy)

Meeting: 2023 International Congress

Abstract Number: 1498

Keywords: Alpha-synuclein, Autonomic nervous system, Denervation

Category: Parkinson's Disease: Molecular Mechanisms of Disease

Objective: To compare α-synuclein oligomers and synaptic density (SD) in skin biopsies from PD and GBA-PD.

Background: Previous research [1] reported α-synuclein oligomers within synaptic terminals of autonomic fibers in skin biopsies from idiopathic Parkinson’s disease (PD) patients employing the proximity ligation assay (PLA), but no information in glucocerebrosidase (GBA)-mutated PD is available.

Method: We collected genetic and clinical data and skin biopsies in 35 patients with PD and 27 with GBA-PD (7 with N370S, 12 with L444P, 8 with compound heterozygous/homozygous mutations or other risk variants). Quantitative analysis was conducted in all the samples containing the sweat gland, which displayed the greatest quantity of autonomic synaptic terminals. The SD was calculated as the ratio between total synaptic terminals and the area of the sweat gland [2], and the α-synuclein oligomers were quantified as the area of PLA signal within synapses normalized for SD.

Results: GBA-PD were younger, had an earlier age at PD onset, and had longer disease duration compared with PD. Orthostatic hypotension was reported in 25.9% of GBA-PD and 20% of PD (p=0.23). No difference in PLA score could be detected between GBA-PD and PD, as well as between different GBA-PD subgroups. Concerning SD, significantly higher values were found in GBA-PD than PD (p<0.001). After controlling in multivariate regression analysis for the effect of age, sex, disease duration, UPDRS-III scores, and Hoehn and Yahr stage, the effect of genetic status was confirmed as a predictor for SD (beta=0.645, 95% CI 0.298-0.752, p<0.001). Interestingly, GBA-PD carrying the N370S mutation displayed higher SD compared with L444P-mutated patients (p=0.05), whereas α-synuclein oligomers did not differ between groups (p=0.8). ROC curve analysis of the SD values showed reliable specificity and sensitivity in detecting GBA-PD (AUC=0.855, p<0.001, sensitivity=85.2%, specificity=77.1%).

Conclusion: The SD values may help to discriminate between GBA-PD and PD.

References: 1. Mazzetti S, Basellini MJ, Ferri V, et al (2020) α-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson’s disease. Brain 143:920–931. doi.org/10.1093/brain/awaa008

2. Navarro-Otano J, Casanova-Mollà J, Morales M, et al (2015) Cutaneous autonomic denervation in Parkinson’s disease. J Neural Transm (Vienna) 122:1149–1155. doi.org/10.1007/s00702-014-1355-3

To cite this abstract in AMA style:

E. Contaldi, S. Mazzetti, M. Basellini, V. Ferri, E. Cereda, I. Isaias, G. Pezzoli, G. Cappelletti. Synaptic density and α-synuclein oligomers in skin biopsies: differences between idiopathic and GBA-linked Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/synaptic-density-and-%ce%b1-synuclein-oligomers-in-skin-biopsies-differences-between-idiopathic-and-gba-linked-parkinsons-disease/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/synaptic-density-and-%ce%b1-synuclein-oligomers-in-skin-biopsies-differences-between-idiopathic-and-gba-linked-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley